In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-21 of 21 for your search:
Cancer Type/Condition:  indolent, contiguous stage II adult non-Hodgkin lymphoma
Stage/Subtype:  indolent, contiguous stage II adult non-Hodgkin lymphoma
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: not specified
Sponsor: NCI, Other
Protocol IDs: 2448.00, NCI-2010-02035, P30CA015704, P01CA018029, NCT01231412

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 95-024, P30CA008748, MSKCC-95024, NCI-V95-0685, NCT00002663

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: PSOC 2502, NCI-2010-00907, P30CA015704, NCT01165112

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2011-203, NCT01609816

5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2011-204, NCT01643603

6.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 05149, P01CA030206, CHNMC-05149, CDR0000579136, NCI-2010-01230, NCT00577278

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 05-0303-04, P30CA023074, CDR0000597508, HSC#0567, UARIZ-SRC17899, UARIZ-HSC-0567, 05-0303-01, NCT00732498

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2292.00, NCI-2009-01302, P30CA015704, NCT00992446

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000683312, E2408, NCI-2011-02644, ECOG-E2408, NCT01216683

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2206.00, NCI-2010-02222, P30CA015704, P01CA018029, NCT01251575

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02625, CDR0000694298, CALGB 50904, U10CA031946, NCT01286272

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02584, 2011C0005, OSU-10156, CDR0000698438, 8834, N01CM62207, N01CM00070, P50CA140158, P30CA016058, OSU-2011C0005, NCT01351896

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, NHLBI
Protocol IDs: 130116, 13-H-0116, NCT01861093

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: IUCRO-0419, CA182947, NCT02078102

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-12215, P30CA016059, R21CA137823, CDR0000652509, MCV-MCC-X05240, MCC-X05240, NCT00963274

16.

Phase: Phase I
Type: Treatment
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: H-29617-GRALE, GRALE, P50CA126752, NCT01555892

17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00792, CALGB-A051103, A051103, P30CA014236, U10CA031946, NCT01829568

18.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: PRS-1, R42CA144104-02, NCT01831505

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: D13067, 3P30CA023108-31S4, NCT01832922

20.

Phase: No phase specified
Type: Health services research, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 040165, 04-C-0165, NCT00923065

21.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 2 and over
Sponsor: NCI, Other
Protocol IDs: CASE1412, NCI-2013-01829, P30CA043703, NCT01959477
New Search